Doximity, Inc. (DOCS) stock analysis

DOCS · Doximity, Inc.

Latest recorded price: USD 32.79

Model-estimated fair value: USD 14.95. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Health Information Services

At $32.79, DOCS trades 119.4% above the model's base-case value of $14.95. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $11.58 in the conservative case and $18.97 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2026 figures: revenue growth 15.5%, free cash flow margin 50.6%, ROIC 23.9%. The model does not flag any risk signals for this company.

Similar companies in Healthcare